Results 231 to 240 of about 2,095,269 (256)

Light Chain Cardiac Amyloidosis With Skeletal Muscle Weakness. [PDF]

JACC Case Rep
Montgomery E, Gorrie N, McCaughan G, Nadel J, Shahi K, Bart NK, Carroll AS.   +6 more
europepmc   +1 more source

Sequential EGFR T790M, MET c.3010C>G-Associated Exon 14 Alteration, and RET-CCDC6 Fusion in EGFR-Mutant NSCLC: A Case Report. [PDF]

Thorac Cancer
Zhu Y, Wang C, Hu NL, Wang DH, Wu SK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus WashoutPhase 3 Report

Ophthalmology, 2022
Shu Min Tang, Jason C S Yam, Xiujuan Zhang   +2 more
exaly  

First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial

Lancet Oncology, The, 2023
Frank Seebach, Emmanuel Okoye, Petra Rietschel   +2 more
exaly  

Continued EGFR-TKI with concurrent radiotherapy to improve time to progression (TTP) in patients with locally progressive non-small cell lung cancer (NSCLC) after front-line EGFR-TKI treatment

Clinical and Translational Oncology, 2017
J Sun
exaly